Oncology News Articles

▼ Show details

The latest Cancer and Oncology news articles published daily by MDLinx physician editors who comb through the top peer-reviewed clinical journals for the medical articles that will make a difference to you and your practice. Organized by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants can stay current on latest oncology topics, symptoms, treatments, risk factors in Cancer and Hematology.

New! >> Start your free Oncology Board Exam Prep course now.
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

1 Everolimus plus exemestane for hormone-receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer: Overall survival results from BOLERO-2 Annals of Oncology, September 30, 2014    Clinical Article

2 First FDA approval of neoadjuvant therapy for breast cancer: Pertuzumab for the treatment of patients with HER2-positive breast cancer Clinical Cancer Research, September 30, 2014    Clinical Article

3 Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus Clinical Gastroenterology and Hepatology , September 30, 2014    Clinical Article

4 Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern Cooperative Oncology Group Trial E3303 Clinical Cancer Research, September 30, 2014    Clinical Article

5 Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases Clinical Cancer Research, September 30, 2014    Clinical Article

6 Sexually transmitted infections and prostate cancer risk: A systematic review and meta-analysis Cancer Epidemiology, September 30, 2014    Review Article

7 Metabolic syndrome factors and risk of postoperative depression in high-grade glioma patients in a 1.5-year prospective study Medical Oncology, September 30, 2014    Clinical Article

8 Prognostic impact of definitive local therapy of the primary tumor in men with metastatic prostate cancer at diagnosis: A population-based, propensity score analysis Cancer Epidemiology, September 30, 2014    Clinical Article

9 Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma Full Text World Journal of Gastroenterology, September 30, 2014    Clinical Article

10 Glucocorticoid prescriptions and breast cancer recurrence: A Danish nationwide prospective cohort study Annals of Oncology, September 30, 2014    Clinical Article

11 Increased nuclear factor erythroid 2-related factor 2 expression predicts worse prognosis of prostate cancer patients treated with radical prostatectomy Human Pathology, September 30, 2014    Clinical Article

12 Adenocarcinoma of the prostate with Gleason pattern 5 on core biopsy: Frequency of diagnosis, morphologic subpatterns, and relation to pattern distribution based on the modified Gleason grading system Human Pathology, September 30, 2014    Clinical Article

13 Five year prostate-specific antigen outcomes after caesium prostate brachytherapy Clinical Oncology, September 30, 2014    Clinical Article

14 Prognostic factors for brain metastases from non-small cell lung cancer with EGFR mutation: Influence of stable extracranial disease and erlotinib therapy Medical Oncology, September 30, 2014    Clinical Article

15 Dexmedetomidine and hydromorphone: A novel pain management strategy for the oncology ward setting during anti-GD2 immunotherapy for high-risk neuroblastoma in children Pediatric Blood & Cancer, September 30, 2014    Clinical Article

16 Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: A report from the children's oncology group phase I consortium Pediatric Blood & Cancer, September 30, 2014    Clinical Article

17 The latest progress in research on triple negative breast cancer (TNBC): Risk factors, possible therapeutic targets and prognostic markers Full Text Journal of Thoracic Disease, September 30, 2014    Review Article

18 Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer Annals of Oncology, September 30, 2014    Clinical Article

19 Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients Annals of Oncology, September 30, 2014    Clinical Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last

Clinical Pearls in Oncology

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Highlights in Oncology

CTC count predicts survival in mBC

As reported in The Lancet Oncology, circulating tumor cell (CTC) quantification in patients (20 studies; n = 1944) with metastatic breast cancer (mBC) predicts progression-free survival (PFS) and overall survival (OS), especially when coupled with clinicopathologic data. A CTC count ≥ 5/7.5 mL at baseline is associated with decreased PFS (HR = 1.92) and OS (HR = 2.78). An elevated CTC count 3-5 weeks and 6-8 weeks after treatment commences is also associated with decreased PFS (HR = 1.85 and 2.20) and OS (HR = 2.26 and 2.91).

Cisplatin monotherapy effective in pediatric high-risk hepatoblastoma

As reported in the Journal of Pediatric Hematology/Oncology, treatment of children with high-risk hepatoblastoma (n=14) with cisplatin monotherapy was as effective as cisplatin + doxorubicin combination therapy, but with less toxicity. The complete resection rate was 78.6%, the event-free survival rate was 81.8%, and the OS rate was 100%.

Immunophenotype of small intestinal adenocarcinoma predicts survival

As reported in the European Journal of Obstetrics and Gynecology & Reproductive Biology, levels of the adipokine, apelin, are decreased in women with PCOS (n=45) compared to healthy controls. Apelin levels are positively correlated with BMI, insulin levels, triglycerides levels, free testosterone levels, the Ferriman-Gallwey score, and the HOMA index. Apelin levels are negatively correlated with HDL levels.


Other Topics in Oncology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close